TRV GP IV, LLC
BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$149.7M2026 Q3
Positions2
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
What Changed This Quarter?
Biggest trim: TNGX -69.5% in shares
New / Increased
0 new · 0 increased
Reduced / Exited
2 reduced · 0 sold out
TNGX
Tango Therapeutics
32.4%
-69.5%
MAZE
Maze Therapeutics
67.6%
-16.8%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.